Sang Won Shin, MD

Articles by Sang Won Shin, MD

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

ByYeul Hong Kim, MD,Sang Won Shin, MD,Byung Soo Kim, MD,Young Tae Park, MD,Jongguk Kim, MD,Jun Suk Kim, MD

September 2nd 1997

Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided

Latest Updated Articles

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma
Published: September 2nd 1997 | Updated:

Sang Won Shin, MD

Articles by Sang Won Shin, MD

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

Latest Updated Articles

Trending on CancerNetwork

ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors

Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer

Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers

Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma

Fruquintinib Combo Prolongs PFS in Advanced/Metastatic RCC